Dergiler / Infectious diseases and clinical microbiology (Online) / 2020 / Cilt: 2 - Sayı: 3

Predictors of Human Papilloma VirusVaccination Uptake among Female UniversityStudents in Turkey

Sayfa
138–146
Yayın Tarihi
2022-10-19
DOI
—
🏛️Bu makalenin bibliyografik verileri ve tam metin bağlantısı DergiPark üzerinden sağlanmıştır.
DergiPark Kaydı ↗
✨

Yapay Zeka Hızlı Bakış & Çıkarımlar

AI Insight
⚡ TL;DR(1 Cümlede Hızlı Çıkarım)

Policies ensuring equitable access and raising awareness hasthe potential to promote the vaccination uptake among youth.

📌 3 Maddede Bu Makale

🎯
Amaç & Hipotez:Introduction: Human Papilloma Virus (HPV) vaccine provides a primary preventionopportunity to decrease the morbidity and mortality of cervical cancer.
📊
Temel Bulgular & Veri:Methods: This is a cross-sectional survey conducted with 1,115 female students viaa questionnaire assessing the sociodemographic characteristics, vaccination uptake,knowledge and attitudes towards HPV and related conditions.Results: 75.2% (n=838) of the participants reported hearing HPV vaccine and 17.9% (n=200)reported they had received at least one dose of HPV vaccine.
💡
Sonuç & Katkı:Policies ensuring equitable access and raising awareness hasthe potential to promote the vaccination uptake among youth.
🔬Tür:Uygulamalı Anket & Alan Araştırması
📍Kapsam:Genişletilmiş Akademik Örneklem
⚙️Değişkenler:Alan Parametreleri

Abstract

Introduction: Human Papilloma Virus (HPV) vaccine provides a primary preventionopportunity to decrease the morbidity and mortality of cervical cancer. Turkey has notyet included it in the national immunization program, but it is commercially available.We aimed to explore the predictors of HPV vaccine uptake among female students in auniversity in Turkey. Methods: This is a cross-sectional survey conducted with 1,115 female students viaa questionnaire assessing the sociodemographic characteristics, vaccination uptake,knowledge and attitudes towards HPV and related conditions.Results: 75.2% (n=838) of the participants reported hearing HPV vaccine and 17.9% (n=200)reported they had received at least one dose of HPV vaccine. The median knowledge scorewas 6 out of 10. Multivariate analysis showed that age (OR: 1.181; 95% CI 1.070-1.304),knowledge score (OR: 1.183; 95% CI 1.075-1.302), department (OR: 1.667; 95% CI 1.087- 2.557), sexual activity (OR: 2.384; 95% CI 1.596-3.561), and level of family income (OR: 3.205;95% CI 2.066-4.970), were significantly associated with vaccination uptake.Conclusion: Our study indicates that the cost of HPV vaccines is an important barrier toequitable access to vaccines. Policies ensuring equitable access and raising awareness hasthe potential to promote the vaccination uptake among youth.

🔖

Bu Makaleye Atıf Yap

ERGÖNÜL, Ö., YAVAŞ, G., UÇURUM, B. E., YILMAZ, P., GÖKÇEK, B., OĞUZER, Ş. E., EĞLENEN, B., KAYI, İ. (2022). Predictors of Human Papilloma VirusVaccination Uptake among Female UniversityStudents in Turkey. Infectious diseases and clinical microbiology (Online), Cilt: 2 - Sayı: 3, 138–146. https://ajindex.com/articles/539095

📄 Tam Metin PDF Okuyucu

📄

PDF görüntüleyici hazırlanıyor...

Kaynakça (8)

  1. 1 Centers for Disease Control and Prevention. Human papillomavirus (HPV) 2020 (cited 2020 Nov 12). Available from: https://www.cdc.gov/hpv/parents/about-hpv.html. 2 Vorsters A, Van Damme P, Bosch FX. HPV vaccination: are we overlooking additional opportunities to control HPV infection and transmission? Int J Infect Dis 2019
  2. 3 World Health Organization. Human papillomavirus (HPV) and cervical cancer 2020 (cited 2020 Nov 12). Available from: https://www.who.int/news-room/fact-sheets/detail/human-papillomavirus-(hpv)-and-cervical-cancer. 4 López N, Torné A, Franco A, San-Martin M, Viayna E, Barrull C, et al. Epidemiologic and economic burden of HPV diseases in Spain: implication of additional 5 types from the 9-valent vaccine. Infect Agent Cancer 2018
  3. 5 Gultekin M, Zayifoglu Karaca M, Kucukyildiz I, Dundar S, Boztas G, Semra Turan H, et al. Initial results of population based cervical cancer screening program using HPV testing in one million Turkish women. Int J Cancer 2018
  4. 6 Bruni L, Albero G, Serrano B, Mena M, Gómez D, Muñoz J, et al. Human Papillomavirus and Related Diseases in Turkey: Summary Report. ICO/IARC Information Centre on HPV and Cancer (HPV Information Centre) 2019. 7 Bruni L, Albero G, Serrano B, Mena M, Gómez D, Muñoz J, et al. Human Papillomavirus and Related Diseases in Europe: Summary Report. ICO/IARC Information Centre on HPV and Cancer (HPV Information Centre). 2019. 8 Williams WW, Lu PJ, Saraiya M, Yankey D, Dorell C, Rodriguez JL, et al. Factors associated with human papillomavirus vaccination among young adult women in the United States. Vaccine 2013
  5. 9 Bednarczyk RA, Birkhead GS, Morse DL, Doleyres H, McNutt LA. Human papillomavirus vaccine uptake and barriers: association with perceived risk, actual risk and race/ethnicity among female students at a New York State university, 2010. Vaccine 2011
  6. 10 Thompson EL, Vamos CA, Vazquez-Otero C, Logan R, Griner S, Daley EM. Trends and predictors of HPV vaccination among U.S. College women and men. Prev Med 2016
  7. 11 Jeannot E, Viviano M, Follonier MC, Kaech C, Oberhauser N, Mpinga EK, et al. Human papillomavirus infection and vaccination: knowledge, attitude and perception among undergraduate men and women healthcare university students in Switzerland. Vaccines (Basel). 2019
  8. 12 Cinar IO, Ozkan S, Aslan GK, Alatas E. Knowledge and behavior of university students toward human papillomavirus and vaccinatio